The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative to develop and validate remote or wearable device-derived biosignatures for monitoring pain in clinical trials. This initiative aims to enhance pain assessment methodologies, ultimately improving treatment outcomes and quality of life for patients suffering from chronic pain. The funding will support multidisciplinary teams in creating digital biosignature algorithms and software, with a total of up to $5.1 million available for 4-6 awards in FY 2024. Interested applicants must submit their proposals by October 5, 2024, and can find additional information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.